Product Approval Breathes New Life Into Boan Biotech IPO
The biosimilar drug maker was approved to sell its second new product in China last month as it applies to list in Hong KongKey Takeaways:Boan Biotechnology has filed for a…
Recent Articles
RELATED ARTICLES
-
Novel drugs lift Sino Biopharm earnings, easing price-cap pain
1177.HK
-
Hutchmed scores U.S. success with cancer drug, but profits still dip
HCM.US 0013.HK
-
CSPC Pharma weighs up diet drug for bigger bottom line
1093.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
CSPC Pharma taps R&D superstar in quest for new breakout drugs
1093.HK
-
Everest reaches new heights on growing drug sales
1952.HK
Discover hidden China stock gems in our weekly newsletter